| 000 | 01522 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250516031447.0 | ||
| 264 | 0 | _c20110926 | |
| 008 | 201109s 0 0 eng d | ||
| 022 | _a1876-7737 | ||
| 024 | 7 |
_a10.1016/j.jprot.2011.03.019 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMarko-Varga, György | |
| 245 | 0 | 0 |
_aDrug localization in different lung cancer phenotypes by MALDI mass spectrometry imaging. _h[electronic resource] |
| 260 |
_bJournal of proteomics _cJun 2011 |
||
| 300 |
_a982-92 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xdrug therapy |
| 650 | 0 | 4 | _aAdenocarcinoma of Lung |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacokinetics |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdrug therapy |
| 650 | 0 | 4 |
_aErbB Receptors _xantagonists & inhibitors |
| 650 | 0 | 4 | _aErlotinib Hydrochloride |
| 650 | 0 | 4 | _aGefitinib |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung _xmetabolism |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aQuinazolines _xpharmacokinetics |
| 650 | 0 | 4 | _aSpectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization |
| 650 | 0 | 4 | _aTandem Mass Spectrometry |
| 700 | 1 | _aFehniger, Thomas E | |
| 700 | 1 | _aRezeli, Melinda | |
| 700 | 1 | _aDöme, Balázs | |
| 700 | 1 | _aLaurell, Thomas | |
| 700 | 1 | _aVégvári, Akos | |
| 773 | 0 |
_tJournal of proteomics _gvol. 74 _gno. 7 _gp. 982-92 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jprot.2011.03.019 _zAvailable from publisher's website |
| 999 |
_c20710196 _d20710196 |
||